VTVT
vTv Therapeutics Inc. Class A Common Stock
stockNASDAQ
vtv therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. we have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 30.52 | 2026-09-28 | +1.02% | -4.608 |
| 1M | 33.35 | 2026-09-04 | -7.56% | 0.376 |
| 3M | 34.54 | 2026-07-06 | -10.74% | 0.239 |
| 6M | 39.54 | 2026-04-06 | -22.03% | 0.963 |
| 1Y | 24.10 | 2025-10-03 | +27.93% | 0.811 |
| 2Y | 14.59 | 2024-10-04 | +111.31% | — |
| 5Y | 67.60 | 2021-10-04 | -54.39% | 0.059 |
vTv Therapeutics Inc. Class A Common Stock (NASDAQ:VTVT) stock price today is $30.83, and today's volume is 18,015. VTVT is down 3.203% today. The 30 day average volume is 45,454. VTVT market cap is $121.90M with 3.95M shares outstanding.